DE69224795D1 - 4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen - Google Patents

4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen

Info

Publication number
DE69224795D1
DE69224795D1 DE69224795T DE69224795T DE69224795D1 DE 69224795 D1 DE69224795 D1 DE 69224795D1 DE 69224795 T DE69224795 T DE 69224795T DE 69224795 T DE69224795 T DE 69224795T DE 69224795 D1 DE69224795 D1 DE 69224795D1
Authority
DE
Germany
Prior art keywords
constituents
lamellar bodies
disclosed
compositions
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69224795T
Other languages
English (en)
Other versions
DE69224795T2 (de
Inventor
James Dobbie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of DE69224795D1 publication Critical patent/DE69224795D1/de
Publication of DE69224795T2 publication Critical patent/DE69224795T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69224795T 1991-05-29 1992-05-29 4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen Expired - Fee Related DE69224795T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70569991A 1991-05-29 1991-05-29
PCT/US1992/004432 WO1992021981A1 (en) 1991-05-29 1992-05-29 Methods and compositions for the prevention, diagnosis, and treatment of inflammatory serosal disease and related conditions

Publications (2)

Publication Number Publication Date
DE69224795D1 true DE69224795D1 (de) 1998-04-23
DE69224795T2 DE69224795T2 (de) 1998-11-19

Family

ID=24834572

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69224795T Expired - Fee Related DE69224795T2 (de) 1991-05-29 1992-05-29 4Verfahren und Zusammensetzungen zur Vorbeugung, Diagnose und Behandlung seröser Entzündungen und damit verbundener Störungen

Country Status (5)

Country Link
EP (1) EP0544862B1 (de)
AT (1) ATE164230T1 (de)
AU (1) AU665764B2 (de)
DE (1) DE69224795T2 (de)
WO (1) WO1992021981A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
US7462618B2 (en) * 2003-08-27 2008-12-09 Sun Health Research Institute Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists
GB0322448D0 (en) 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
WO2005030226A1 (en) * 2003-09-25 2005-04-07 Lamellar Therapeutics Limited Compositions and methods of using lamellar bodies for therapeutic purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
AU620821B2 (en) * 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
CA2005190A1 (en) * 1988-12-12 1990-06-12 Morgan Van Aken Detection of basement membrane components as diagnostic of cancer and other diseases
WO1991006006A1 (fr) * 1989-10-19 1991-05-02 Yamasa Shoyu Kabushiki Kaisha Excipient de liaison d'anticorps antiphospholipides, immuno-analyse utilisant cet excipient et kit associe

Also Published As

Publication number Publication date
EP0544862B1 (de) 1998-03-18
AU665764B2 (en) 1996-01-18
AU2011892A (en) 1993-01-08
DE69224795T2 (de) 1998-11-19
WO1992021981A1 (en) 1992-12-10
EP0544862A1 (de) 1993-06-09
ATE164230T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
Forni et al. Radiofrequency destruction of the tuberoinfundibular region of hypothalamus permanently abrogates NK cell activity in mice
Mattson et al. Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
EP1140170A4 (de) Neue substanzen und methoden zur behandlung und diagnose von okularen krankheiten
DE69830185D1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
BR0011000A (pt) Métodos para prevenir ou tratar uma doença associada com depósitos amilóides de ab no cérebro de um paciente, para avaliar um anticorpo quanto á atividade de remoção de uma entidade biológica fisicamente associada com um antìgeno e para detectara um depósito amilóide em um paciente, composição farmacêutica, e, conjunto de diagnóstico
DE59705683D1 (de) IMMUNOLOGISCHES NACHWEISVERFAHREN VON ANTIKÖRPERN, DIE GEGEN GEWEBE-TRANSGLUTAMINASE (tTG) GERICHTET SIND, VERWENDUNG VON tTG ZUR DIAGNOSE UND THERAPIEKONTROLLE SOWIE ORALES PHARMAZEUTISCHES MITTEL ENTHALTEND tTG
Reid et al. Pathology illustrated E-book
DE69028712D1 (de) Zusammensetzung zur behandlung entzündlicher darmerkrankungen
Shavit-Stein et al. Blocking thrombin significantly ameliorates experimental autoimmune neuritis
Garcia-Monco et al. Mechanisms of injury in Lyme neuroborreliosis
Theakston An objective approach to antivenom therapy and assessment of first-aid measures in snake bite
ATE164230T1 (de) 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen
Yokota et al. Persistent increased threshold of electrical stimulation selective to motor nerve in multifocal motor neuropathy
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
JP2005187472A (ja) 抗ｔｎｆ治療と組み合わせた体外フォトフェレーシス
Serup et al. Bone mineral content in systemic sclerosis measured by photonabsorptiometry
Cameron et al. Multiple sclerosis basics
Tyler Double‐blind study of modified neurotoxin in motor neuron disease
WO2012136522A1 (de) Antikörperprodukt, umfassend n spezifische antikörper
DE60127935T2 (de) Verfahren zur diagnose der effektivität der xenotypischen antikörpertherapie
Konkol et al. Schilder's disease: additional aspects and a therapeutic option
McDonald et al. Focal upper limb neuropathy in a child
LICHTENSTEIN et al. WILSON'S DISEASE—CHRONIC FORM: Clinical-Pathological Observations in a Brother and Sister
Light The antigenicity of bovine thrombin: clinical evaluation
Engel Polyneuropathy in type 2 diabetes mellitus

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee